Patents Assigned to Biocogniv Inc.
  • Patent number: 11676722
    Abstract: A method of determining the risk of developing a known disease or condition or of identifying the presence of the known disease or condition in a subject includes obtaining subject data that includes results of blood tests. The blood tests include a basic metabolic panel (BMP) and a complete blood count (CBC) panel. The method further includes classifying the subject data with respect to the risk of the subject having or developing the known disease or condition by using the subject data in a machine learning classification system. The classification system includes a machine learning model previously trained on BMP and CBC data from a positive group of training subjects who received a diagnosis of the disease or condition and from a negative group of training subjects who were not diagnosed to have the disease or condition.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: June 13, 2023
    Assignee: Biocogniv Inc.
    Inventors: Artur B. Adib, Tanya S. Kanigan, Robert A. Levine